Adicet Bio, Inc.
ACET
$0.6736
$0.00260.39%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 28.29M | 27.63M | 27.36M | 26.94M | 26.53M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 127.62M | 128.44M | 128.09M | 130.13M | 132.58M |
| Operating Income | -127.62M | -128.44M | -128.09M | -130.13M | -132.58M |
| Income Before Tax | -117.12M | -117.88M | -137.29M | -139.79M | -142.66M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -117.12 | -117.88 | -137.29 | -139.79 | -142.66 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -117.12M | -117.88M | -137.29M | -139.79M | -142.66M |
| EBIT | -127.62M | -128.44M | -128.09M | -130.13M | -132.58M |
| EBITDA | -121.15M | -121.91M | -121.50M | -123.63M | -126.48M |
| EPS Basic | -1.34 | -1.70 | -2.53 | -2.95 | -3.32 |
| Normalized Basic EPS | -0.83 | -1.07 | -1.30 | -1.56 | -1.79 |
| EPS Diluted | -1.34 | -1.70 | -2.53 | -2.95 | -3.32 |
| Normalized Diluted EPS | -0.83 | -1.07 | -1.30 | -1.56 | -1.79 |
| Average Basic Shares Outstanding | 351.40M | 303.59M | 255.72M | 208.04M | 171.93M |
| Average Diluted Shares Outstanding | 351.40M | 303.59M | 255.72M | 208.04M | 171.93M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
